A health systems analysis of global head and neck cancer outcomes.

E Edward Christopher Dee A Adrian E. Go (Cebu Institute of Medicine, Cebu City, Philippines) E Erin Feliciano (2Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, New York, United States) J James Fan Wu (Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI) J Jonas Willmann (Department of Radiation Oncology University Hospital Zurich University of Zurich Zurich Switzerland) K Kaitlyn Lapen (1Memorial Sloan Kettering Cancer Center, New York, United States) T Teeradon Treechairusame (Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand) M Milit S. Patel S Sruthi Ranganathan A Alessandro Hammond (Harvard University, Cambridge, Massachusetts, United States) Y Yingzhi Wu (Memorial Sloan Kettering Cancer Center, New York, NY) A Annu Singh (Memorial Sloan Kettering Cancer Center, New York, NY) A Andrew M. Wong (Yale University, New Haven, CT) L Luisa Jacomina (Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines) J Jennifer Ma (Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY) P Puneeth Iyengar C Cherry Estilo (Memorial Sloan Kettering Cancer Center, New York, NY) T T. Peter Kingham N Nancy Y. Lee

Abstract

e18092 Background: Head and neck cancers (HNC) remain a major global cause of cancer morbidity and mortality, with disproportionately poor outcomes in low- and middle-income countries. Marked cross-national disparities suggest an important role for health system strengthening. We evaluated associations between national health system characteristics and global HNC outcomes. Methods: We conducted a cross-sectional ecological analysis of 185 countries using sex-stratified, age-standardized incidence and mortality estimates from the International Agency for Research on Cancer (IARC) GLOBOCAN 2022 database. The primary outcome was the composite mortality-to-incidence ratio (MIR) for aggregated HNCs, including cancers of the lip and oral cavity, oropharynx, larynx, nasopharynx, hypopharynx, and salivary gland. We evaluated 11 national health system indicators spanning health financing, workforce density, service availability, socioeconomic development, and gender equity. Univariable linear regressions identified candidate variables using Bonferroni correction (P<0.0045), followed by multivariable modeling with assessment for multicollinearity using variance inflation factor analysis (VIF>10 prompting removal). Results: All 11 health system indicators were significantly associated with HNC MIR in univariable analyses (P<.001 for all). In multivariable analysis restricted to countries with complete covariate data (n=123), higher Universal Health Coverage (UHC) service coverage index and higher gross domestic product (GDP) per capita were independently associated with lower (improved) HNC MIR. The model demonstrated strong predictive power (model R²=0.70; VIF for all <10). On analysis stratified by sex, UHC index and GDP per capita were similarly independently associated with improved MIR for HNCs. Conclusions: Our global cross-national analysis demonstrates that universal health coverage and national economic capacity are independently associated with improved head and neck cancer mortality-to-incidence ratios, underscoring the central role of health system strength in shaping outcomes. These findings highlight how investments in healthcare access, financial protection, and resource availability may help narrow global disparities in HNC.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (19)

E

Edward Christopher Dee

A

Adrian E. Go

Cebu Institute of Medicine, Cebu City, Philippines

E

Erin Feliciano

2Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, New York, United States

J

James Fan Wu

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

J

Jonas Willmann

Department of Radiation Oncology University Hospital Zurich University of Zurich Zurich Switzerland

K

Kaitlyn Lapen

1Memorial Sloan Kettering Cancer Center, New York, United States

T

Teeradon Treechairusame

Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

M

Milit S. Patel

S

Sruthi Ranganathan

A

Alessandro Hammond

Harvard University, Cambridge, Massachusetts, United States

Y

Yingzhi Wu

Memorial Sloan Kettering Cancer Center, New York, NY

A

Annu Singh

Memorial Sloan Kettering Cancer Center, New York, NY

A

Andrew M. Wong

Yale University, New Haven, CT

L

Luisa Jacomina

Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines

J

Jennifer Ma

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

P

Puneeth Iyengar

C

Cherry Estilo

Memorial Sloan Kettering Cancer Center, New York, NY

T

T. Peter Kingham

N

Nancy Y. Lee